The journey toward value-based care models for health systems has not been without its challenges, both financially and operationally. Strategic collaborations across the healthcare ecosystem can be a key part of advancing a value-based care strategy. The Centers for Medicare & Medicaid Services (CMS) recently announced a key milestone towards its stated goal of moving 100% of traditional Medicare beneficiaries into accountable care relationships focused on quality and total cost of care by 2030. As of January 2025, more than half of people with traditional (fee-for-service) Medicare are in an accountable care relationship with a provider. This webinar will provide actionable steps for how healthcare leaders can evaluate, initiate and deliver strategic collaborations, including best practices from a healthcare system and pharma manufacturer joint effort. This session will illustrate how healthcare leaders can work together to assess opportunities and build, implement and measure solutions.

As lifespans are increasing, so too is the burden of chronic disease. Meanwhile, diseases that once largely affected older populations are now afflicting younger people too. Yet only around 3% of total health spending in wealthy countries is dedicated to prevention, meaning people live with diseases that could have been prevented or controlled earlier, and health systems must deal with the consequences. At GSK, we believe that getting ahead of disease is the best investment — for people, healthcare systems and economies.

We know that vaccines are still one of the best health interventions, and the societal and economic returns on investing in vaccination are significant. But vaccines are just one of the ways we can intervene early to change the course of disease. Watch GSK’s CEO Emma Walmsley, along with President of Global Health Deborah Waterhouse and Head of Vaccines R&D Phil Dormitzer, discuss how science and technology can help to prevent illness in the first place and stop disease in its tracks.